The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.
- Conditions
- Elevated Blood PressureHypertension
- Interventions
- Other: PlaceboOther: Pumpkin Seed Oil
- Registration Number
- NCT03716960
- Lead Sponsor
- Marymount University
- Brief Summary
Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO).
The investigators hypothesis is that PSO would improve CV health in postmenopausal women.
- Detailed Description
The purpose of the study is to examine the effects of 6 weeks of PSO on arterial and autonomic function in postmenopausal women. Specific aims of the study are to:
To investigate the extent to which PSO will improve cardiovascular disease risk factors by assessing arterial stiffness, aortic BP and wave reflection, and autonomic function (heart rate variability).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 23
- Female
- 45 to 65 years of age
- At least 1 year after menopause
- BMI <39.9
- Sedentary or low active (less than 2 hr per wk)
- known heart disease
- peripheral vascular disease
- diabetes, body mass index
- BMI> 40 kg/m2
- other chronic diseases
- taking medications (e.g., hormone replacement therapy, beta blockers, calcium channel blockers, antidepressants and stimulants) that could affect the outcome variables
- smokers
- history of steady exercise or received exercise training and dietary changes in the last year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo This arm involved 6 weeks of placebo consumption. Subject consumed 1 capsule of maltodextrin with each main meal of the day to match the dose and number of capsules ingested daily by the PSO group. Pumpkin Seed Oil Pumpkin Seed Oil This arm involved 6 weeks of PSO consumption. Subject were supplemented with 3 g/day of PSO which was ingested in the form of 1g capsules with each main meal of the day (breakfast, lunch and dinner). Likewise,
- Primary Outcome Measures
Name Time Method Blood pressure 6 weeks Non-invasive measures of brachial and aortic blood pressure
Pressure Wave Reflection 6 weeks Using the augmentation index
Arterial Stiffness 6 weeks Using the stiffness index
Heart rate variability 6 weeks R-R intervals were collected during 6 min using a validated wireless monitor (Polar 800CX; Polar Electro OY, Kempele, Finland) via a chest strap interfaced with a PC. All R-R intervals were inspected for artifacts and premature beats.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Marymount University
🇺🇸Arlington, Virginia, United States